Bulk Inquiry
Quininib
- Soluble in DMSO
- MF: C17H13NO
- MW: 247.29
Description
Antagonist of the cysteinyl leukotriene receptor 1 and 2 (CysLT1-2; IC50 values 1.4 μM and 38.5 μM, respectively). Quininib robustly inhibits developmental angiogenesis in zebrafish (at 4-10 μM), and significantly inhibits angiogenic tubule formation in HMEC-1 cells, angiogenic sprouting in aortic ring explants and retinal revascularisation in OIR mice, independently of VEGF receptors. Moreover, using ex vivo human CRC explants, Quininib significantly reduced the secretions of angiogenic growth factors and inflammatory cytokines IL-6, IL-8, VEGF, ENA-78, GRO-α, TNF, IL-1β and MCP-1.
More Information
| Parent CAS No. | 143816-42-6 |
|---|---|
| Chemical Name | (E)-2-(2-(quinolin-2-yl)vinyl)phenol |
| SMILES | C1(O)=CC=CC=C1/C=C/C1C=CC2C(N=1)=CC=CC=2 |
| MFCD | N.A. |
| InChi | InChI=1S/C17H13NO/c19-17-8-4-2-6-14(17)10-12-15-11-9-13-5-1-3-7-16(13)18-15/h1-12,19H/b12-10+ |
| InChiKey | NXNDEWNGCMCWMA-ZRDIBKRKSA-N |
| CID | 135411330 |
| Short Description | CysLT antagonist |
References
- AL Reynolds et al. Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis. J Biol Chem. 2016 Apr 1;291(14):7242-55.
- O Galvin et al. A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo. J Control Release. 2016 Jul 10;233:198-207.
- AG Murphy et al. Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer. Sci Rep. 2016 Oct 14;6:34523.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1310 | Myoseverin |
From $137.50 |
| 1418 | JWH 133 |
From $132.00 |
| 1420 | Pazopanib hydrochloride |
From $66.00 |
| 1461 | Cediranib |
From $77.00 |
| 1547 | OSI 930 |
From $99.00 |
| 1548 | LBH 589 |
From $99.00 |
| 1699 | Temsirolimus |
From $104.50 |
| 1768 | AMG 706 |
From $115.50 |
| 1793 | Lenalidomide |
From $44.00 |
| 2234 | SSR 128129E |
From $121.00 |
| 2332 | OTX 008 |
From $137.50 |
| 2553 | LY 2801653 |
From $132.00 |
| 2738 | CysLT1 Antagonist Q8 |
From $104.50 |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.